Slide 1MEND-CABG II ACC08 LBCT JHA, 1 John H. Alexander, MD, MS, FACC Robert W. Emery, MD, FACC On behalf of the MEND-CABG II Investigators A Randomized, Double-blind, Placebo-controlled,…
Slide 1SORT-OUT III: A Prospective Randomized Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients with Coronary Artery Disease Michael Maeng, Klaus…
Slide 1Introduction to Forensic Science & to the Law Chapter 1 Slide 2 Forensic Science It is the study and application of science to matters of law (criminal and civil)…
Slide 1Covariates in Repeated-Measures Analyses Repeated Measures What change has occurred (in response to a treatment)? Mechanism Variables How much of the change was due…
Slide 1The Role of Statistics Post-Market Jay Herson, Ph.D. Johns Hopkins University Sept 29, 2006 Slide 2 Post-Market Trials Phase IV Label extension or modification Surveillance…
Slide 1BAYESIAN ADAPTIVE DESIGN & INTERIM ANALYSIS Donald A. Berry [email protected] Donald A. Berry [email protected] Slide 2 2 2 Some references l Berry DA…
Slide 1Prognostic Model Building with Biomarkers in Pharmacogenomics Trials Li-an Xu & Douglas Robinson Statistical Genetics & Biomarkers Exploratory Development,…
Slide 1 Slide 2 THE RISKS OF LIFE Video Conference 5 Media & Misinformation Slide 3 Slide 4 Newspaper Headlines Daily Mail Obesity worse for cancer than smoking Is anything…